Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universite De Strasbourg (Unistra) manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to 1 distinct examiner and 1 distinct art unit. The university's current USPTO activity is focused on one specific biotechnological innovation. This concentrated approach allows for a dedicated prosecution strategy that addresses the specific technical requirements of the 1 distinct art unit involved.
BROWN, MINDY G is the busiest examiner for the portfolio, handling 1 pending office action. This 1 examiner is responsible for the entirety of the university's pending workload. Prosecution efforts are concentrated on the specific requirements and examination style of this individual within the 1 distinct art unit. Practitioners should tailor their legal arguments to the specific preferences of BROWN, MINDY G to advance the application.
With only 1 pending office action, the university does not have to manage multiple examiners or art units. However, this also means that the university's entire active patent presence is dependent on the outcome of this single matter. Practitioners should carefully review the standards of the Biotechnology & Pharmaceuticals technology area to ensure that the application is positioned for a favorable review by the 1 distinct examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560221 | METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19 | BROWN, MINDY G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560221 | METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19 | BROWN, MINDY G | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560221 | METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19 | BROWN, MINDY G | 1635 | §101§102 | Non-Final OA | — | Pending | Nov 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversite De Strasbourg (Unistra) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mindy G Brown has the most, with 1 of Universite De Strasbourg (Unistra)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.